← Back
$EL All transactions

ESTEE LAUDER COMPANIES INC

▼ SELL

$ Value

$590K

Shares

6,417

Price

$92

Filed

Aug 28

Insider

Name

La Lande Rashida

Title

Executive VP & General Counsel

CIK

0001728090

Roles

Officer

Transaction Details

Transaction Date

2025-08-28

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Payout of shares upon vesting of portion of Restricted Stock Units ("RSUs") granted August 27, 2024. | Not applicable. | Represents the withholding of shares for tax purposes. | The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. | Sales prices range from $91.88 to $91.91 per share, inclusive. | RSUs vest and are paid out in shares of Class A Common Stock on a one-to-one basis on the applicable vesting date. RSUs generally vest in three approximately equal installments unless otherwise indicated. Upon payout, shares are withheld to cover statutory tax obligations. RSUs are accompanied by dividend equivalent rights payable in cash at the time of the payout of the related shares. | Non-annual RSUs granted August 27, 2024. Assuming continued employment, these RSUs will vest and be paid out as follows: 14,357 on August 27, 2026; and 14,357 on August 27, 2027.

Filing Info

Accession No.

0001728090-25-000006

Form Type

4

Issuer CIK

0001001250

La Lande Rashida's History

Date Ticker Type Value
2025-11-26 EL $151K
2025-11-03 EL M
2025-11-03 EL F $188K
2025-11-03 EL M
2025-08-28 EL $590K
2025-08-28 EL A
2025-08-28 EL A
2025-08-28 EL A
2025-08-27 EL M
2025-08-27 EL F $726K

Other Insiders at EL (90d)

Insider Bought Sold Last
LAUDER RONALD S
Chairman, Clinique Labs, LLC
2026-04-08
LAUDER AERIN 2026-04-08